P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 457 500 KRW -5.96%
Market Cap: 4.8T KRW

Intrinsic Value

The intrinsic value of one PharmaResearch Co Ltd stock under the Base Case scenario is 544 421.45 KRW. Compared to the current market price of 457 500 KRW, PharmaResearch Co Ltd is Undervalued by 16%.

Intrinsic Value
544 421.45 KRW
Undervaluation 16%
Intrinsic Value
Price
P
Worst Case
Base Case
Best Case

Valuation History
PharmaResearch Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about PharmaResearch Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PharmaResearch Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for PharmaResearch Co Ltd.

Explain Valuation
Compare PharmaResearch Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PharmaResearch Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
PharmaResearch Co Ltd

Current Assets 691.6B
Cash & Short-Term Investments 539.2B
Receivables 70.9B
Other Current Assets 81.6B
Non-Current Assets 296.7B
Long-Term Investments 86.5B
PP&E 166.6B
Intangibles 33.8B
Other Non-Current Assets 9.8B
Current Liabilities 92B
Accounts Payable 12B
Other Current Liabilities 80B
Non-Current Liabilities 235.3B
Long-Term Debt 201.5B
Other Non-Current Liabilities 33.8B
Efficiency

Free Cash Flow Analysis
PharmaResearch Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
PharmaResearch Co Ltd

Revenue
496B KRW
Cost of Revenue
-118.6B KRW
Gross Profit
377.4B KRW
Operating Expenses
-181.9B KRW
Operating Income
195.5B KRW
Other Expenses
-44.3B KRW
Net Income
151.2B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

PharmaResearch Co Ltd's profitability score is 70/100. The higher the profitability score, the more profitable the company is.

Exceptional ROIC
Positive 3Y Average ROIC
ROIC is Increasing
Exceptional Operating Margin
70/100
Profitability
Score

PharmaResearch Co Ltd's profitability score is 70/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

PharmaResearch Co Ltd's solvency score is 92/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Low D/E
92/100
Solvency
Score

PharmaResearch Co Ltd's solvency score is 92/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
PharmaResearch Co Ltd

Wall Street analysts forecast PharmaResearch Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PharmaResearch Co Ltd is 781 632.33 KRW with a low forecast of 646 400 KRW and a high forecast of 1 245 365.21 KRW.

Lowest
Price Target
646 400 KRW
41% Upside
Average
Price Target
781 632.33 KRW
71% Upside
Highest
Price Target
1 245 365.21 KRW
172% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for PharmaResearch Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one PharmaResearch Co Ltd stock?

The intrinsic value of one PharmaResearch Co Ltd stock under the Base Case scenario is 544 421.45 KRW.

Is PharmaResearch Co Ltd stock undervalued or overvalued?

Compared to the current market price of 457 500 KRW, PharmaResearch Co Ltd is Undervalued by 16%.

Back to Top